HEMARINA

Hemarina SA. is a privately held biotechnology company focused on the research, and development of oxygen-carriers for medical applications. Dr. Franck Zal, an expert in the field of invertebrate hemoglobin and oxygen transport, founded Hemarina after having spent more than fourteen years in academic research centers (CNRS, University of California at Santa Barbara USA and University of Antwerpen, Belgium) studying the relationships between the structure and function of invertebrate respiratory... pigment (annelid’s extracellular hemoglobin and crustacean hemocyanin). The discoveries arising from his research on extracellular hemoglobin coming from marine invertebrates and their effective oxygen transport system have been patented and published in numerous scientific journals and form the basis of Hemarina’s technologies. Hemarina’s approach to the development of oxygen transport agents is based on the observation of marine worms colonizing extreme environments and the study of their respiratory adaptations. Hemarina’s lead product, HbAm, is designed to deliver oxygen effectively and efficiently to tissues at risk of oxygen deprivation. Hemarina has already a passed panel of strong proof of concepts obtained during preclinical trials.
HEMARINA
Industry:
Biotechnology Medical Device Product Research
Founded:
2007-03-01
Address:
Morlaix, Bretagne, France
Country:
France
Website Url:
http://www.hemarina.com
Total Employee:
11+
Status:
Active
Contact:
+33 2 98 88 14 02
Email Addresses:
[email protected]
Total Funding:
4.79 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Current Employees Featured
Founder
Investors List
Armor Angels
Armor Angels investment in Series C - Hemarina
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Series C - Hemarina
Finistère Angels
Finistère Angels investment in Series C - Hemarina
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Series B - Hemarina
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Series A - Hemarina
Finistere Ventures
Finistere Ventures investment in Series A - Hemarina
AGORANOV
AGORANOV investment in Series A - Hemarina
Official Site Inspections
http://www.hemarina.com Semrush global rank: 4.34 M Semrush visits lastest month: 2.62 K
- Host name: web1.anaximandre.com
- IP address: 87.98.151.65
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris

More informations about "Hemarina"
Hemarina - Crunchbase Company Profile & Funding
Hemarina SA. is a privately held biotechnology company focused on the research, and development of oxygen-carriers for medical applications. Dr. …See details»
Hemarina - Hemarina
Hemarina is a biopharmaceutical company specialized in the development of health products via its proprietary technology platform (M101) based on the properties of Lugworm (Arenicola …See details»
the first universal oxygen carrier for therapeutic …
Technology at Hemarina revolves around the hemoglobin found in the marine worm Arenicola marina. This hemoglobin is very similar in structure to that found in humans, but differs by: Its extra-cellular nature. It is not contained within red …See details»
Hemarina - Hemarina
Hemarina est une société de Biotechnologie spécialisée dans le développement de produits de santé issus de sa plateforme technologique propriétaire (M101) qui repose sur les propriétés …See details»
Hemarina 2025 Company Profile: Valuation, Funding
Hemarina was founded in 2007. Where is Hemarina headquartered? Hemarina is headquartered in Morlaix, France. What is the size of Hemarina? Hemarina …See details»
Hémarina - Bioregate
General activities Hemarina is a biotechnology company created in 2007 which has its head office in Morlaix (Finistère). The company is centered on the development of universal marine …See details»
Hemarina - Company Profile - Tracxn
Feb 23, 2025 Hemarina - Research and development of oxygen-carriers for medical applications. Raised a total funding of $26.6M over 5 rounds from 7 investors. Founded by …See details»
Hemarina - Crunchbase
Hemarina is a biotechnology company focused on the research and development of oxygen carriers for medical applications.See details»
HEMARINA - VentureRadar
QuartzBio USA n/a Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting …See details»
Hemarina Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Hemarina. See Hemarina company profile and funding data.See details»
Hemarina - Funding, Financials, Valuation & Investors - Crunchbase
Hemarina is a biotechnology company focused on the research and development of oxygen carriers for medical applications. New. Resources. Advanced Search. ... How much funding …See details»
Hemarina Company Profile - Office Locations, Competitors ... - Craft
Hemarina offers products that constitute a decisive technological breakthrough in regard to current or past developments of hemoglobin-based oxygen carriers (HBOCs). Hemarina’s lead …See details»
HEMARINA - Le 1er transporteur d'oxygène universel à visée ...
Le dispositif médical HEMO2life® contenant un transporteur d’oxygène issu du ver marin arénicole de la société Hemarina, facilitant la conservation Lire la suite. Actualités. Actualite. 5 …See details»
HEMARINA - Atlanpole Biotherapies
HEMARINA is a biotechnology start-up based in Morlaix (France); developing innovative solutions based on marine molecules for patients and healthcare industry : universal oxygen carriers’ …See details»
The therapeutic potential of a marine oxygen carrier - CQDM
Apr 18, 2024 HEMARINA is developing several innovations: an additive to organ transplant graft preservation solutions (HEMO2life®), an oxygenating dressing (HEMHealing®), a treatment …See details»
Hémarina - Bioregate
Ainsi, HEMARINA se positionne sur des marchés à forte valeur ajoutée avec une vision de multiples partenaires potentiels et non de réels concurrents. Notre business model repose sur …See details»
Hemarina : une révolution dans le transport d’oxygène
Mar 8, 2025 Hemarina a mis au point HEMO2life®, une solution enrichie en hémoglobine d’arénicole qui prolonge la viabilité des greffons en leur apportant un flux constant d’oxygène. …See details»
Therapeutic Potential of Hemoglobin Derived from the Marine …
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... Franck Zal is the cofounder and …See details»
Team Einarson announces departure of lead Briane Harris, who …
1 day ago The CCES is an independent organization responsible for administering Canada’s anti-doping program. The sources spoke on the condition of anonymity because the complaint …See details»
HEMO2life® - Hemarina
Hemarina and Delpharm announce the signing of a partnership for the manufacture of HEMO 2 life ® November 29, 2018. DOWNLOAD THE PRESS RELEASE. Brest University Hospital …See details»